Eli Lilly ordered to pay $176.5 mln to Teva in U.S. migraine drug patent trial
By Blake BrittainNov 9 (Reuters) - Eli Lilly & Co must pay Teva Pharmaceuticals International GmbH $176.5 million after a trial to determine whether...
By Blake BrittainNov 9 (Reuters) - Eli Lilly & Co must pay Teva Pharmaceuticals International GmbH $176.5 million after a trial to determine whether...